Highlights
- FY 2023 Group sales at $32.2 billion, -4% versus prior year
- Q4 Group sales grew to $7.9 billion, +5% versus prior year
- FY 2023 EBITDA at $4.6 billion, -18% versus prior year
- Q4 EBITDA at $1.0 billion, +15% versus prior year
- Syngenta Group China achieved strong 11% year-over-year sales growth, reaching $9.6 billion in FY 2023
- FY 2023 MAP and digital sales in China grew 26% versus prior year
- Continued demand in an overall challenging Crop Protection market environment for new innovative technologies
- Insect-control products containing PLINAZOLIN® technology achieving particularly strong sales across Brazil and Asia Pacific
- Insect-control products containing PLINAZOLIN® technology achieving particularly strong sales across Brazil and Asia Pacific
Highlights
- FY 2023 Group sales at $32.2 billion, -4% versus prior year
- Q4 Group sales grew to $7.9 billion, +5% versus prior year
- FY 2023 EBITDA at $4.6 billion, -18% versus prior year
- Q4 EBITDA at $1.0 billion, +15% versus prior year
- Syngenta Group China achieved strong 11% year-over-year sales growth, reaching $9.6 billion in FY 2023
- FY 2023 MAP and digital sales in China grew 26% versus prior year
- Continued demand in an overall challenging Crop Protection market environment for new innovative technologies
- Insect-control products containing PLINAZOLIN® technology achieving particularly strong sales across Brazil and Asia Pacific
- Insect-control products containing PLINAZOLIN® technology achieving particularly strong sales across Brazil and Asia Pacific